Table 7.
Relationship of the Apo C111 Genotype with the Lipid Spectrum in the Kazakhs with Coronary Heart Disease (CHD)
| Parameters | SISI | SIS2 | S2S2 | P1 | P2 | P3 |
|---|---|---|---|---|---|---|
| (mmol/l) | (n = 97) | (n = 50) | (n = 14) | |||
| TC (mmol/l) | 5.42±0.07 | 5.44±0.08 | 5.43±0.25 | >0,05 | >0,05 | >0,05 |
| HDLC | 0.91±0.03 | 0.92±0.05 | 0.91±0.12 | >0,05 | >0,05 | >0,05 |
| TG | 2.8±0.06 | 2.5±0.07 | 2.1±0.22 | <0,05 | <0,05 | >0,05 |
| LDLC | 3.95±0.09 | 4.02±0.08 | 4.1±0.26 | >0,05 | >0,05 | >0,05 |
| VlDLPC | 0.56±0.01 | 0.5±0.02 | 0.42±0.06 | <0,05 | <0,05 | >0,05 |
| AI (relative unit) | 4.95±0.17 | 4.91±0.20 | 4.97±0.36 | >0,05 | >0,05 | >0,05 |
| Apo A1 (mg/dl) | 136.74±2.63 | 138.0±2.88 | 139.8± 4.39 | >0,05 | >0,05 | >0,05 |
| Apo B (mg/dl) | 105.1±2.87 | 104.0±2.96 | 103.5±4.36 | >0,05 | >0,05 | >0,05 |
| Apo E (mg/dl) | 6.8±0.22 | 6.7±0.32 | 6.9±0.65 | >0,05 | >0,05 | >0,05 |
Note: P1 – Statistical differences of lipid parameters in patients with the SISI and SIS2 genotypes, P2 – Statistical differences of lipid parameters in patients with the SISI and S1S2 genotypes, P3 – Statistical differences of lipid parameters in patients with the SIS2 and S2S2 genotypes.